Welcome!
Morningstar Healthcare Observer Journal
Delivering a Comprehensive, Unbiased View on the Healthcare Industry
Leveraging Morningstar's comprehensive industry coverage, Morningstar Healthcare Observer examines complex healthcare topics and trends to provide critical insight. Through cross-industry analysis, we bring together Morningstar analysts from different healthcare industries to research significant issues.

The Healthcare sector is large, complex, continually evolving and very influential. What happens here can influence other sectors as well, especially when it comes to identifying the next big development or opportunity. Healthcare Observer offers a way to stay on top of it all and find sound, unbiased insight in one source.

Free 3-Article Supplement » Click to get your free preview of Morningstar Healthcare Observer.
Coverage Of Critical Topics
US Healthcare Reform. With the prospect of 40 million uninsured gaining some form of coverage, what is the upside and downside for the healthcare sector and related industries like insurance?

Mergers and Acquisitions. Why large firms, flush with cash, may step up to the table, and what different types of companies have to gain from acquiring or being acquired.

The Patent Cliff and Big Pharma's Cost Cuts. Why contract research organizations may benefit from outsourced drug development.

Targeted Cancer Drugs. Scientific advancement and unexpected profits have created a paradigm shift in developing new cancer drugs in tandem with diagnostic tools.

Drug Pricing. With select groups of drugs reaching annual pricing of $100,000 and several new high-priced drugs on the way, we'll evaluate whether our health-care system can manage the costs.

Innovation in Cardiovascular Stents. We will review the outlook for cardiovascular procedures and the market for stents.

The Next Decade in Eye Care. Baby boomers are getting older, and the demand for eye-related pharmaceuticals and treatment devices is expected to grow.

Generic At-Risk Launches vs. Reverse Settlements. What branded drugs are most at risk?

The Future of Health-Care IT. How President Obama's plans for lowering drug costs might be a boon for the information technology world.

Erythropoientin (EPO) Trends. Combined analysis from our biotech, dialysis center and pharmaceutical analysts will pull the pieces together.

R&D in a Post Vioxx Environment. As patent expirations plague the pharmaceutical industry, the majority are outsourcing drug development.

What the Team Delivers

12 Healthcare Observer Journals delivered monthly to your email box.

In-depth commentary for scientific and economic trends.

Unbiased view on specific companies and their performance.

Cross-Industry Analysis—in and out of the healthcare sector.

Our take on industry-shaping topics at conferences.

Calendar of events as well as regulatory & study release dates.

The Weekly Round Up—where our team dissects key events weekly, via email.

Members-Only Conference Calls.

E-mail Access to Our Analyst Team.

16 Free Monthly and Quarterly Bonus Reports. Monthly deep dives into a specific company or industry. Quarterly comprehensive, issue-focused reports on subjects like M&A, Healthcare Spending, US Reform, CRO and more.

Download a Free 3-Article Supplement
Get a sneak peek of Morningstar Healthcare Observer.
Click here to download a free preview issue »

The Morningstar Guarantee If you are unhappy with our newsletter for any reason, cancel within 30 days of the start date by calling toll free, 1-866-910-1145 for a full refund. After that, you may cancel at any time, and we will refund the remaining months left on your subscription. Your satisfaction is our priority.
Published monthly
Member-Only Conference Calls
Full access to the Observer Web site
16 Free Reports
Weekly Roundup E-mails About Key Events
One Year $1195 $895
Save 25% off your first year!
Click here to browse our issue archive and purchase single issues of Healthcare observer for $99 ($149 for Premium members).

To order by phone, call 866-910-1145. If you are outside the US, please call 312-384-3838.

Contact Us | © Morningstar Healthcare Observer. All rights reserved.